These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31691640)

  • 1. Long-term frailty modeling using a non-proportional hazards model: Application with a melanoma dataset.
    Calsavara VF; Milani EA; Bertolli E; Tomazella V
    Stat Methods Med Res; 2020 Aug; 29(8):2100-2118. PubMed ID: 31691640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival models induced by zero-modified power series discrete frailty: Application with a melanoma data set.
    Molina KC; Calsavara VF; Tomazella VD; Milani EA
    Stat Methods Med Res; 2021 Aug; 30(8):1874-1889. PubMed ID: 33955295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonproportional hazards model with a frailty term for modeling subgroups with evidence of long-term survivors: Application to a lung cancer dataset.
    Gazon AB; Milani EA; Mota AL; Louzada F; Tomazella VLD; Calsavara VF
    Biom J; 2022 Jan; 64(1):105-130. PubMed ID: 34569095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective 3-parameter Gompertz model with frailty term for estimating cure fraction in survival data.
    Hajizadeh N; Baghestani AR; Pourhoseingholi MA; Khadem Maboudi AA
    J Biopharm Stat; 2023 Jan; 33(1):90-113. PubMed ID: 35671330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weighted Lindley frailty model: estimation and application to lung cancer data.
    Mota A; Milani EA; Calsavara VF; Tomazella VLD; Leão J; Ramos PL; Ferreira PH; Louzada F
    Lifetime Data Anal; 2021 Oct; 27(4):561-587. PubMed ID: 34331190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A flexible class of generalized joint frailty models for the analysis of survival endpoints.
    Chauvet J; Rondeau V
    Stat Med; 2023 Apr; 42(8):1233-1262. PubMed ID: 36775273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new long-term survival model with dispersion induced by discrete frailty.
    Cancho VG; Macera MAC; Suzuki AK; Louzada F; Zavaleta KEC
    Lifetime Data Anal; 2020 Apr; 26(2):221-244. PubMed ID: 30968271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-Cox model for non-proportional hazards survival analysis with frailty.
    Begun A; Kulinskaya E; Ncube N
    Stat Med; 2023 Aug; 42(18):3114-3127. PubMed ID: 37190904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bivariate survival model with compound Poisson frailty.
    Wienke A; Ripatti S; Palmgren J; Yashin A
    Stat Med; 2010 Jan; 29(2):275-83. PubMed ID: 19856276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penalized likelihood estimation of a mixture cure Cox model with partly interval censoring-An application to thin melanoma.
    Webb A; Ma J; Lô SN
    Stat Med; 2022 Jul; 41(17):3260-3280. PubMed ID: 35474515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of frailties into a cure rate regression model and its diagnostics and application to melanoma data.
    Leão J; Leiva V; Saulo H; Tomazella V
    Stat Med; 2018 Dec; 37(29):4421-4440. PubMed ID: 30109718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Firth adjusted score function for monotone likelihood in the mixture cure fraction model.
    Almeida FM; Colosimo EA; Mayrink VD
    Lifetime Data Anal; 2021 Jan; 27(1):131-155. PubMed ID: 33184683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A general class of semiparametric transformation frailty models for nonproportional hazards survival data.
    Choi S; Huang X
    Biometrics; 2012 Dec; 68(4):1126-35. PubMed ID: 23005582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A transformation class for spatio-temporal survival data with a cure fraction.
    Hurtado Rúa SM; Dey DK
    Stat Methods Med Res; 2016 Feb; 25(1):167-87. PubMed ID: 22514030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cure rate models for heterogeneous competing causes.
    Brandão M; Leão J; Gallardo DI; Bourguignon M
    Stat Methods Med Res; 2023 Sep; 32(9):1823-1841. PubMed ID: 37489264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semiparametric accelerated failure time cure rate mixture models with competing risks.
    Choi S; Zhu L; Huang X
    Stat Med; 2018 Jan; 37(1):48-59. PubMed ID: 28983935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonproportional hazards and unobserved heterogeneity in clustered survival data: When can we tell the difference?
    Balan TA; Putter H
    Stat Med; 2019 Aug; 38(18):3405-3420. PubMed ID: 31050028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A class of semiparametric cure models with current status data.
    Diao G; Yuan A
    Lifetime Data Anal; 2019 Jan; 25(1):26-51. PubMed ID: 29423775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A general class of promotion time cure rate models with a new biological interpretation.
    Gómez YM; Gallardo DI; Bourguignon M; Bertolli E; Calsavara VF
    Lifetime Data Anal; 2023 Jan; 29(1):66-86. PubMed ID: 36114312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified score function for monotone likelihood in the semiparametric mixture cure model.
    Almeida FM; Colosimo EA; Mayrink VD
    Biom J; 2022 Mar; 64(3):635-654. PubMed ID: 34845768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.